Mucosal Melanoma
📧 Sign up to get email alerts when something new happens for Mucosal Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma [Phase 2]
A Phase 2 trial evaluating YH003 in combination with Pebolizumab and albumin paclitaxel for unresectable/metastatic mucosal melanoma has com…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) [Phase 1]
HAMMER I is a Phase I trial evaluating hepatic ablation of melanoma liver metastases to enhance response to immunotherapy; the study status …
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma [Phase 2]
Phase 2 trial of atezolizumab plus bevacizumab in unresectable mucosal melanoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery [Phase 3]
A Phase 3 trial comparing high-dose recombinant interferon alfa-2B or ipilimumab to pembrolizumab in patients with surgically removed stage …
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Molecular Characterization of Primary Mucosal Melanoma
This clinical trial update reports molecular characterization of primary mucosal melanoma and notes the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract [NA]
A clinical trial update indicates recruitment for a carbon ion radiotherapy study targeting mucosal melanoma of the female lower genital tra…
-
CLINICAL_TRIALS withdrawal · 2024-06-26Clinical Trial Update: Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma [Phase 2]
A Phase 2 neoadjuvant trial of pembrolizumab plus lenvatinib for mucosal melanoma has been withdrawn.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma [Phase 1]
A Phase 1 clinical trial update describing AK104 or AK112 in combination with Axitinib for metastatic mucosal melanoma, currently not yet re…
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Neoadjuvant and Adjuvant Checkpoint Blockade [Phase 2]
A Phase 2 neoadjuvant and adjuvant checkpoint blockade trial in melanoma completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab [Phase 2]
Phase 2 trial studying nivolumab plus ipilimumab in advanced acral lentiginous melanoma and mucosal melanoma; terminated with posted results…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma [Phase 2]
Phase 2 trial evaluating the timing of pembrolizumab around surgery in high-risk melanoma, comparing post-operative administration to strate…
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists [Phase 1, Phase 2]
Phase I/II trial evaluating LPV7 vaccine with TLR agonists in melanoma showed completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma [Phase 2]
A Phase 2 clinical trial evaluating envafolimab combined with recombinant human endostatin and first-line chemotherapy for advanced mucosal …
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma [Phase 2]
A Phase 2 study compares the combination of ipilimumab and nivolumab versus ipilimumab alone in advanced melanoma, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma [Phase 2]
A Phase 2 trial assessing the combination of ipilimumab and nivolumab as adjuvant treatment for mucosal melanoma is listed as active but not…
-
CLINICAL_TRIALS trial_result · 2022-01-31Clinical Trial Update: Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma [Phase 2]
Phase 2 trial investigating toripalimab in combination with axitinib for localized mucosal melanoma is ongoing, with status currently unknow…
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study [Phase 2]
Phase II study update on postoperative adjuvant treatment for completely resected mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma [Phase 2]
Phase 2 trial update of lenvatinib plus pembrolizumab for neoadjuvant treatment in resectable mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery [Phase 2]
Phase 2 clinical trial update comparing JS001 to high-dose interferon in patients with mucosal melanoma that has been surgically removed.
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma [Phase 2]
Phase 2 trial update on maintenance treatment with toripalimab (JS001) in unresectable locally advanced or metastatic mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating nab-paclitaxel with bevacizumab or ipilimumab as first-line therapy in patients with unresectable stage IV melanoma…
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma [Phase 2]
Phase II clinical trial update for advanced mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma. [Phase 2]
Phase 2 trial update evaluating the combination of CM082 with JS001 in patients with advanced mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Apatinib Plus SHR1210 in Advanced Mucosal Melanoma [Phase 2]
Phase 2 trial evaluating apatinib plus SHR1210 in advanced mucosal melanoma; currently status unknown.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma [Phase 2]
Phase 2 study evaluating epacadostat with a vaccine therapy in patients with stage III-IV melanoma has completed and posted results.